Induction of HIV-1 gag specific immune responses by cationic micelles mediated delivery of gag mRNA

References

• Aliabadi HM, Landry B, Bahadur RK, et al. (2011). Impact of lipid substitution on assembly and delivery of siRNA by cationic polymers. Macromol Biosci 11:662–72
   PubMed Web of Science ®Google Scholar
• Alshamsan A, Haddadi A, Incani V, et al. (2009). Formulation and delivery of siRNA by oleic acid and stearic acid modified polyethylenimine. Mol Pharm 6:121–33
   PubMed Web of Science ®Google Scholar
• Amano T, Kajiwara K, Yoshikawa K, et al. (2007). Antitumor effects of vaccination with dendritic cells transfected with modified receptor for hyaluronan-mediated motility mRNA in a mouse glioma model. J Neurosurg 106:638–45
   PubMed Web of Science ®Google Scholar
• Bettinger T, Carlisle RC, Read ML, et al. (2001). Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells. Nucleic Acid Res 29;3882–91
   PubMed Web of Science ®Google Scholar
• Bringmann A, Held SAE, Heine A, Brossart P. (2010). RNA vaccines in cancer treatment. J Biomed Biotechnol 2010:623687--98
   PubMedGoogle Scholar
• Cho YW, Kim JD, Park K. (2003). Polycation gene delivery systems: escape from endosomes to cytosol. J Pharm Pharmacol 55:721–34
   PubMed Web of Science ®Google Scholar
• Doria-Rose NA, Haigwood NL. (2003). DNA vaccine strategies: candidates for immune modulation and immunization regimens. Methods 31:207–16
   PubMed Web of Science ®Google Scholar
• Fischer D, Bieber T, Li Y, et al. (1999). A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res 16:1273–9
   PubMed Web of Science ®Google Scholar
• Fotin-Mleczek M, Duchardt KM, Lorenz C, et al. (2011). Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity. J Immunother 34:1–15
   PubMed Web of Science ®Google Scholar
• Godbey WT, Wu KK, Mikos AG. (1999). Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater Res 45:268–75
   PubMed Web of Science ®Google Scholar
• Inaba K, Inaba M, Romani N, et al. (1992). Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176:1693–702
   PubMed Web of Science ®Google Scholar
• Kariko K, Kuo A, Barnathan E. (1999). Overexpression of urokinase receptor in mammalian cells following administration of the in vitro transcribed encoding mRNA. Gene Ther 6:1092–100
   PubMed Web of Science ®Google Scholar
• Kreiter S, Diken M, Selmi A, et al. (2011). Tumor vaccination using messenger RNA: prospects of a future therapy. Curr Opin Immunol 23:399–406
   PubMed Web of Science ®Google Scholar
• Li M, Jiang YH, Xu, CQ, et al. (2013). Enhanced immune response against HIV-1 induced by a heterologous DNA prime-adenovirus boost vaccination using mannosylated polyethyleneimine as DNA vaccine adjuvant. Int J Nanomed 8:1843–54
   PubMed Web of Science ®Google Scholar
• Liu ZH, Zhang ZY, Zhou CR, Jiao, YP. (2010). Hydrophobic modifications of cationic polymers for gene delivery. Prog Polym Sci 35:1144–62
   Web of Science ®Google Scholar
• Malone RW, Felgner PL, Verma IM. (1989). Cationic liposome-mediated RNA transfection. Proc Natl Acad Sci USA 86:6077–81
   PubMed Web of Science ®Google Scholar
• Mockey M, Bourseau E, Chandrashekhar V, et al. (2007). mRNA-based cancer vaccine: prevention of B16 melanoma progression and metastasis by systemic injection of MART1 mRNA histidylated lipopolyplexes. Cancer Gene Ther 14:802–14
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Symonds P, Murray JC, et al. (2005). A two-stage poly(ethylenimine)-mediated cytotoxicity: Implications for gene transfer/therapy. Mol Ther 11:990–5
   PubMed Web of Science ®Google Scholar
• Mosmann T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Method 65:55–63
   PubMed Web of Science ®Google Scholar
• Navarro G, Pan J, Torchilin VP. (2015). Micelle-like nanoparticles as carriers for DNA and siRNA. Mol Pharm 12:301--13
   PubMed Web of Science ®Google Scholar
• Nishiya T, Kajita E, Miwa S, Defranco AL. (2005). TLR3 and TLR7 are targeted to the same intracellular compartments by distinct regulatory elements. J Biol Chem 280:7–17
   Web of Science ®Google Scholar
• Pack DW, Hoffman AS, Pun S, Stayton PS. (2005). Design and development of polymers for gene delivery. Nat Rev Drug Discov 4:581–93
   PubMed Web of Science ®Google Scholar
• Palumbo RN, Zhong X, Wang C. (2012). Polymer-mediated DNA vaccine delivery via bystander cells requires a proper balance between transfection efficiency and cytotoxicity. J Control Rel 157:86–93
   PubMed Web of Science ®Google Scholar
• Perche F, Benvegnu T, Berchel M, et al. (2011). Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA. Nanomedicine 7:445–53
   PubMed Web of Science ®Google Scholar
• Petsch, B, Schnee, M, Vogel, AB, et al. (2012). Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection. Nat Biotechnol 30:1210--16
   PubMed Web of Science ®Google Scholar
• Phua, KKL, Nair, SK, Leong, KW. (2014). Messenger RNA (mRNA) nanoparticle tumour vaccination. Nanoscale 6:7715–29
   PubMed Web of Science ®Google Scholar
• Probst J, Brechtel S, Scheel B, et al. (2006). Characterization of the ribonuclease activity on the skin surface. Genet Vaccines Ther 4:4--12
   PubMedGoogle Scholar
• Qiu Y, Guo L, Zhang S, et al. (2015). DNA-based vaccination against hepatitis B virus using dissolving microneedle arrays adjuvanted by cationic liposomes and CpG ODN. Drug Deliv 27:1–8
   Google Scholar
• Rittig SM, Haentschel M, Weimer KJ, et al. (2011). Intradermal vaccinations with rna coding for taa generate CD8(+) and CD4(+) immune responses and induce clinical benefit in vaccinated patients. Mol Ther 19:990–9
   PubMed Web of Science ®Google Scholar
• Shi SJ, Zhong ZR, Liu J, et al. (2012). Solid lipid nanoparticles loaded with anti-microrna Oligonucleotides (AMOs) for suppression of microRNA-21 functions in human lung cancer cells. Pharm Res 29:97–109
   PubMed Web of Science ®Google Scholar
• Steitz J, Britten CM, Wolfel T, Tuting T. (2006). Effective induction of anti-melanoma immunity following genetic vaccination with synthetic mRNA coding for the fusion protein EGFP.TRP2. Cancer Immunol Immunother 55:246–253
   PubMed Web of Science ®Google Scholar
• Su XF, Fricke J, Kavanagh DG, Irvine DJ. (2011). In vitro and in vivo mRNA delivery using lipid-enveloped ph-responsive polymer nanoparticles. Mol Pharm 8:774–87
   PubMed Web of Science ®Google Scholar
• Tavernier G, Andries O, Demeester J, et al. (2011). mRNA as gene therapeutic: how to control protein expression. J Control Release 150:238–47
   PubMed Web of Science ®Google Scholar
• Uchida S, Itaka K, Uchida H, et al. (2013). In vivo messenger RNA introduction into the central nervous system using polyplex nanomicelle. PLoS One 8:e56220
   PubMed Web of Science ®Google Scholar
• Weide B, Carralot JP, Reese A, et al. (2008). Results of the first phase I/II clinical vaccination trial with direct injection of mRNA. J Immunother 31:180–8
   PubMed Web of Science ®Google Scholar
• Weide B, Pascolo S, Scheel B, et al. (2009). Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients. J Immunother 32:498–507
   PubMed Web of Science ®Google Scholar
• Wong SY, Pelet JM, Putnam D. (2007). Polymer systems for gene delivery-past, present, and future. Prog Polym Sci 32:99–837
   Web of Science ®Google Scholar
• Yamamoto A, Kormann M, Rosenecker J, Rudolph C. (2009). Current prospects for mRNA gene delivery. Eur J Pharm Biopharm 71:484–9
   PubMed Web of Science ®Google Scholar
• Yu H, Babiuk LA, Littel-Van Den Hurk SV. (2007). Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis CNS3/4A mRNA. Vaccine 25:1701–11
   PubMed Web of Science ®Google Scholar
• Zarei S, Arrighi JF, Ongaro G, et al. (2003). Efficient induction of CD8 T-associated immune protection by vaccination with mRNA transfected dendritic cells. J Invest Dermatol 121:745–50
   PubMed Web of Science ®Google Scholar
• Zeng Q, Jiang H, Wang T, et al. (2014). Cationic micelle delivery of Trp2 peptide for efficient lymphatic draining and enhanced cytotoxic T-lymphocyte responses. J Control Release 200:1–12
   PubMed Web of Science ®Google Scholar
• Zhang HM, Zhang LW, Ren J, et al. (2006). Induction of alpha-fetoprotein-specific CD4-and CD8-mediated T-cell response using RNA-transfected dendritic cells. Cell Immunol 239:144–50
   PubMed Web of Science ®Google Scholar
• Zohra FT, Chowdhury EH, Tada S, et al. (2007). Effective delivery with enhanced translational activity synergistically accelerates mRNA-based transfection. Biochem Biophys Res Commun 358:373–8
   PubMed Web of Science ®Google Scholar